Xu L - Search Results

1

A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer.

Wen T, Wang Z, Li Y, Li Z, Che X, Fan Y, Wang S, Qu J, Yang X, Hou K, Zhou W, Xu L, Li C, Wang J, Liu J, Chen L, Zhang J, Qu X, Liu Y. Wen T, et al. Among authors: xu l. Cancer Immunol Res. 2017 Jul;5(7):524-534. doi: 10.1158/2326-6066.CIR-16-0381. Epub 2017 Jun 15. Cancer Immunol Res. 2017. PMID: 28619967

2

Trastuzumab and oxaliplatin exhibit a synergistic antitumor effect in HER2-postive gastric cancer cells.

Ding X, Qu X, Fan Y, Che X, Qu J, Xu L, Liu J, Liu Y. Ding X, et al. Among authors: xu l. Anticancer Drugs. 2014 Mar;25(3):315-22. doi: 10.1097/CAD.0000000000000048. Anticancer Drugs. 2014. PMID: 24300914

3

Cbl-b enhances sensitivity to 5-fluorouracil via EGFR- and mitochondria-mediated pathways in gastric cancer cells.

Feng D, Ma Y, Liu J, Xu L, Zhang Y, Qu J, Liu Y, Qu X. Feng D, et al. Among authors: xu l. Int J Mol Sci. 2013 Dec 16;14(12):24399-411. doi: 10.3390/ijms141224399. Int J Mol Sci. 2013. PMID: 24351824 Free PMC article.

4

Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells.

Yan S, Qu X, Xu L, Che X, Ma Y, Zhang L, Teng Y, Zou H, Liu Y. Yan S, et al. Among authors: xu l. Anticancer Drugs. 2014 Jul;25(6):683-9. doi: 10.1097/CAD.0000000000000095. Anticancer Drugs. 2014. PMID: 24710190

5

Cetuximab-induced MET activation acts as a novel resistance mechanism in colon cancer cells.

Song N, Liu S, Zhang J, Liu J, Xu L, Liu Y, Qu X. Song N, et al. Among authors: xu l. Int J Mol Sci. 2014 Apr 4;15(4):5838-51. doi: 10.3390/ijms15045838. Int J Mol Sci. 2014. PMID: 24714091 Free PMC article.

6

Src/caveolin-1-regulated EGFR activation antagonizes TRAIL-induced apoptosis in gastric cancer cells.

Xu L, Qu X, Li H, Li C, Liu J, Zheng H, Liu Y. Xu L, et al. Oncol Rep. 2014 Jul;32(1):318-24. doi: 10.3892/or.2014.3183. Epub 2014 May 15. Oncol Rep. 2014. PMID: 24840271

7

Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells.

Li H, Xu L, Li C, Zhao L, Ma Y, Zheng H, Li Z, Zhang Y, Wang R, Liu Y, Qu X. Li H, et al. Among authors: xu l. Mol Cancer. 2014 Jun 2;13:136. doi: 10.1186/1476-4598-13-136. Mol Cancer. 2014. PMID: 24885194 Free PMC article.

8

Insulin-like growth factor-I induces epithelial to mesenchymal transition via GSK-3β and ZEB2 in the BGC-823 gastric cancer cell line.

Li H, Xu L, Zhao L, Ma Y, Zhu Z, Liu Y, Qu X. Li H, et al. Among authors: xu l. Oncol Lett. 2015 Jan;9(1):143-148. doi: 10.3892/ol.2014.2687. Epub 2014 Nov 7. Oncol Lett. 2015. PMID: 25435948 Free PMC article.

9

Cetuximab-induced insulin-like growth factor receptor I activation mediates cetuximab resistance in gastric cancer cells.

Li X, Xu L, Li H, Zhao L, Luo Y, Zhu Z, Liu Y, Qu X. Li X, et al. Among authors: xu l. Mol Med Rep. 2015 Jun;11(6):4547-54. doi: 10.3892/mmr.2015.3245. Epub 2015 Jan 23. Mol Med Rep. 2015. PMID: 25625229

10

Cbl-b inhibits P-gp transporter function by preventing its translocation into caveolae in multiple drug-resistant gastric and breast cancers.

Zhang Y, Qu X, Teng Y, Li Z, Xu L, Liu J, Ma Y, Fan Y, Li C, Liu S, Wang Z, Hu X, Zhang J, Liu Y. Zhang Y, et al. Among authors: xu l. Oncotarget. 2015 Mar 30;6(9):6737-48. doi: 10.18632/oncotarget.3253. Oncotarget. 2015. PMID: 25788263 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,193 results

Search Page

Filters